Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Saved in:
Bibliographic Details
Title: Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Authors: Contreras-Toledo, Débora1 (AUTHOR) ct.debora@gmail.com, Jiménez-Fonseca, Paula1 (AUTHOR), López, Carlos López2 (AUTHOR), Montes, Ana Fernández3 (AUTHOR), López Muñoz, Ana María4 (AUTHOR), Vázquez Rivera, Francisca5 (AUTHOR), Alonso, Vicente6 (AUTHOR), Alcaide, Julia7 (AUTHOR), Salvà, Francesc8 (AUTHOR), Covela Rúa, Marta9 (AUTHOR), Guillot, Mónica10 (AUTHOR), Martín Carnicero, Alfonso11 (AUTHOR), Jimeno Mate, Raquel12 (AUTHOR), Cameselle García, Soledad3 (AUTHOR), Asensio Martínez, Elena13 (AUTHOR), González Astorga, Beatriz14 (AUTHOR), Fernandez-Diaz, Amaya B.15 (AUTHOR), González Villaroel, Paula16 (AUTHOR), Virgili Manrique, Anna C.17 (AUTHOR), Melián Sosa, Marcos18 (AUTHOR)
Source: British Journal of Cancer. Mar2024, Vol. 130 Issue 5, p777-787. 11p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/s41416-023-02563-w